Edges in Network
Network | GSE6481_top8000 - GSE6481 - SiGN-BN NNSR |
Network Description | Gene Expression Analysis of Soft Tissue Sarcomas: Characterization & Reclassification of Malignant Fibrous Histiocytoma |
Node | HLA-DMA |
Upstream (Parents) |
---|
(<<) HLA-DRA → HLA-DMA |
(<<) FCER1G → HLA-DMA |
(<<) HLA-DRB1 → HLA-DMA |
Downstream (Children) |
---|
HLA-DMA → HCLS1 (>>) |
HLA-DMA → VAMP8 (>>) |
HLA-DMA → TRBC1///TRBC2 (>>) |
HLA-DMA → CPA3 (>>) |
HLA-DMA → SLAMF8 (>>) |
HLA-DMA → ARHGAP15 (>>) |
HLA-DMA → LASS1///GDF1 (>>) |
HLA-DMA → BIN2 (>>) |
HLA-DMA → HLA-DQA2///HLA-DQA1 (>>) |
HLA-DMA → CCL2 (>>) |
HLA-DMA → IL21R (>>) |
HLA-DMA → TMEM176B (>>) |
HLA-DMA → LAMP3 (>>) |
HLA-DMA → CECR1 (>>) |
HLA-DMA → TBXAS1 (>>) |
HLA-DMA → ACP5 (>>) |
HLA-DMA → HMHA1 (>>) |
HLA-DMA → HLA-DRA (>>) |
HLA-DMA → LCK (>>) |
HLA-DMA → TRAC///TRA@ (>>) |
HLA-DMA → HLA-DPA1 (>>) |
HLA-DMA → CD72 (>>) |
HLA-DMA → PTPRC (>>) |
HLA-DMA → CD86 (>>) |
HLA-DMA → PCSK2 (>>) |
HLA-DMA → SRGN (>>) |
HLA-DMA → ENTPD1 (>>) |
HLA-DMA → CFI (>>) |
HLA-DMA → PLAU (>>) |
HLA-DMA → GIMAP4 (>>) |
HLA-DMA → BATF (>>) |
HLA-DMA → SQRDL (>>) |
HLA-DMA → CCL4 (>>) |
HLA-DMA → CD74 (>>) |
HLA-DMA → MNDA (>>) |
HLA-DMA → SP140 (>>) |
HLA-DMA → ICAM1 (>>) |
HLA-DMA → LTB (>>) |
HLA-DMA → CD37 (>>) |
HLA-DMA → MYOF (>>) |
HLA-DMA → LYL1 (>>) |
HLA-DMA → TLR2 (>>) |
HLA-DMA → FCER1G (>>) |
HLA-DMA → NCF2 (>>) |
HLA-DMA → AOAH (>>) |
HLA-DMA → DALRD3 (>>) |
HLA-DMA → HLA-DMB (>>) |
HLA-DMA → CTSZ (>>) |
HLA-DMA → TNFSF13 (>>) |
HLA-DMA → C11orf75 (>>) |
HLA-DMA → WARS (>>) |
HLA-DMA → HLA-DRB1 (>>) |
HLA-DMA → TNFSF12-TNFSF13///TNFSF12///TNFSF13 (>>) |
HLA-DMA → TFEB (>>) |
HLA-DMA → CD4 (>>) |
HLA-DMA → LCP1 (>>) |
HLA-DMA → HLA-B (>>) |
HLA-DMA → SHC2 (>>) |
HLA-DMA → LYN (>>) |